PRRT2 and Hyperglycemia: Hyperglycemia triggers several pathological pathways that promote neuronal and vascular damage, such as the deposition of advanced glycation end products (AGEs), the activation of protein kinase C (PKC), and the enhanced polyol pathway, which results in high levels of intracellular ROS.